(19)
(11)
EP 1 176 978 A2
(12)
(88)
Date of publication A3:
26.04.2001
(43)
Date of publication:
06.02.2002
Bulletin 2002/06
(21)
Application number:
00932163.9
(22)
Date of filing:
05.05.2000
(51)
International Patent Classification (IPC)
7
:
A61K
39/21
,
A61K
39/39
,
A61P
31/18
(86)
International application number:
PCT/US0012/495
(87)
International publication number:
WO 0067/787
(
16.11.2000
Gazette 2000/46)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
06.05.1999
US 132762 P
25.08.1999
US 150667 P
(71)
Applicant:
THE IMMUNE RESPONSE CORPORATION
Carlsbad, CA 92008 (US)
(72)
Inventor:
MOSS, Ronald, B.
San Diego, CA 92130 (US)
(74)
Representative:
UEXKÜLL & STOLBERG
Patentanwälte Beselerstrasse 4
22607 Hamburg
22607 Hamburg (DE)
(54)
HIV IMMUNOGENIC COMPOSITIONS AND METHODS